AKAP9 antibody (N-Term)
Quick Overview for AKAP9 antibody (N-Term) (ABIN570727)
Target
See all AKAP9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- N-Term
-
Purpose
- AKAP9 / YOTIAO
-
Sequence
- QRKAQSDGQS PSKK
-
Specificity
- This antibody is expected to recognize isoforms 2 and 3 (NP_005742.4, NP_671714.1)
-
Cross-Reactivity
- Dog, Human
-
Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence QRKAQSDGQSPSKK-C, from the N Terminus of the protein sequence according to NP_005742.4, NP_671714.1.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Western Blot: Not yet tested - our routinely used western blotting protocol does not allow detection of proteins as large as the calculated size of 453 kDa according to NP_005742.4. Therefore we cannot recommend an optimal concentration and the antibody i
Peptide ELISA: antibody detection limit dilution 1:64000.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- AKAP9 (A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))
-
Alternative Name
- AKAP9
-
Background
- AKAP9, A kinase (PRKA) anchor protein (yotiao) 9, AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, MU-RMS-40.16A, PRKA9, YOTIAO, A-kinase anchor protein 9, A-kinase anchor protein, 350 kDa, A-kinase anchoring protein 450, AKAP120-like protein, AKAP9-BRAF fusi
-
Gene ID
- 10142
-
NCBI Accession
- NP_005742, NP_671714
-
Pathways
- M Phase, SARS-CoV-2 Protein Interactome
Target
-